130 related articles for article (PubMed ID: 19383302)
21. [Detection and prognostic significance of micrometastasis in peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation therapy].
Chen TF; Jiang GL; Zhang YQ; Wang LJ; Fu XL; Qian H; Wu KL; Zhao S
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):365-8. PubMed ID: 17892133
[TBL] [Abstract][Full Text] [Related]
22. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
[TBL] [Abstract][Full Text] [Related]
23. Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer.
Marrakchi R; Ouerhani S; Benammar S; Rouissi K; Bouhaha R; Bougatef K; Messai Y; Khadimallah I; Rahal K; Ben Ammar-Elgaaied A
Int J Biol Markers; 2008; 23(4):238-43. PubMed ID: 19199272
[TBL] [Abstract][Full Text] [Related]
24. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
[TBL] [Abstract][Full Text] [Related]
25. Non-coding CK19 RNA in peripheral blood and tissue of breast cancer patients.
Oloomi M; Yardehnavi N; Bouzari S; Moazzezy N
Acta Med Iran; 2013 Mar; 51(2):75-86. PubMed ID: 23585313
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the MUC1 Gene in Iranian Women with Breast Cancer Micrometastasis.
Mansouri N; Movafagh A; Soleimani S; Taheri M; Hashemi M; Heidary Pour A; Alizadeh Shargh S; Mosavi-Jarahi A; Sasaninejad Z; Zham H; Hajian P; Allah Moradi H; Mirzaei HR; Fardmanesh H; Ohadi M
Asian Pac J Cancer Prev; 2016; 17(S3):275-8. PubMed ID: 27165238
[TBL] [Abstract][Full Text] [Related]
27. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period.
Ge MJ; Shi D; Wu QC; Wang M; Li LB
J Cancer Res Clin Oncol; 2006 Apr; 132(4):248-56. PubMed ID: 16320073
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
[TBL] [Abstract][Full Text] [Related]
29. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients.
Farmen RK; Nordgård O; Gilje B; Shammas FV; Kvaløy JT; Oltedal S; Heikkilä R
Breast Cancer Res Treat; 2008 Mar; 108(2):251-8. PubMed ID: 17492378
[TBL] [Abstract][Full Text] [Related]
31. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.
Kahn HJ; Yang LY; Blondal J; Lickley L; Holloway C; Hanna W; Narod S; McCready DR; Seth A; Marks A
Breast Cancer Res Treat; 2000 Mar; 60(2):143-51. PubMed ID: 10845277
[TBL] [Abstract][Full Text] [Related]
32. Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.
Apostolaki S; Perraki M; Pallis A; Bozionelou V; Agelaki S; Kanellou P; Kotsakis A; Politaki E; Kalbakis K; Kalykaki A; Vamvakas L; Georgoulias V; Mavroudis D
Ann Oncol; 2007 May; 18(5):851-8. PubMed ID: 17301075
[TBL] [Abstract][Full Text] [Related]
33. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
34. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR.
Berois N; Varangot M; Aizen B; Estrugo R; Zarantonelli L; Fernández P; Krygier G; Simonet F; Barrios E; Musé I; Osinaga E
Eur J Cancer; 2000 Apr; 36(6):717-23. PubMed ID: 10762743
[TBL] [Abstract][Full Text] [Related]
35. Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamous cell carcinoma.
Dyavanagoudar S; Kale A; Bhat K; Hallikerimath S
Indian J Dent Res; 2008; 19(4):315-9. PubMed ID: 19075434
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.
Uen YH; Lin SR; Wu CH; Hsieh JS; Lu CY; Yu FJ; Huang TJ; Wang JY
Clin Chim Acta; 2006 May; 367(1-2):55-61. PubMed ID: 16403482
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection.
Daskalakis M; Mavroudis D; Sanidas E; Apostolaki S; Askoxylakis I; de Bree E; Georgoulias V; Melissas J
Eur J Surg Oncol; 2011 May; 37(5):404-10. PubMed ID: 21376504
[TBL] [Abstract][Full Text] [Related]
38. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
39. Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.
Reinholz MM; Kitzmann KA; Tenner K; Hillman D; Dueck AC; Hobday TJ; Northfelt DW; Moreno-Aspitia A; Roy V; LaPlant B; Allred JB; Stella PJ; Lingle WL; Perez EA
Clin Cancer Res; 2011 Nov; 17(22):7183-93. PubMed ID: 21976532
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
